BioDelivery Sciences (NSDQ:BDSI) is a specialty pharmaceutical company that last year achieved a 617% growth rate, as shown in Deloitte’s 2020 Technology Fast 500 Rankings. The company is focused on meeting unmet needs of patients with chronic conditions. We interviewed Scott Plesha, the company’s president and chief commercial officer, to learn more about the company. In…